ConductScience.org, home

Paper42913630PubMed

Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade.

Patra D and 17 others. Cell, 2026.

Cite this record

ConductScience Library. Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade. Papers, record 42913630. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42913630

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lifestyle-induced regulatory T cell fragility primes adverse events after immune checkpoint blockade.
Journal
Cell
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-06

Source PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Patra DDipyaman
2Wolfgang KKatelyn
3Ye CChenxian
4Rigatti LLora
5Ertwine KKelsey
6Morder KMKristin M
7Jana JJessica
8Baral IIshita
9Hurd DDrew
10Bossong KKaitlin
11Mullett SSteven
12Dou YYingtong
13Gelhaus SStacy
14Vignali DAADario A A
15Davar DDiwakar
16Cillo ARAnthony R
17Delgoffe GMGreg M
18Overacre-Delgoffe AEAbigail E

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R35 CA263850NCI NIH HHSUnited StatesR35CA263850PubMedNIH RePORTER
DP2 AI177967NIAID NIH HHSUnited StatesDP2AI177967PubMedNIH RePORTER
P30 CA047904NCI NIH HHSUnited StatesP30CA047904PubMedNIH RePORTER
R01 AI171483NIAID NIH HHSUnited StatesR01AI171483PubMedNIH RePORTER
P50 CA121973NCI NIH HHSUnited StatesP50CA121973PubMedNIH RePORTER
R01 CA277473NCI NIH HHSUnited StatesR01CA277473PubMedNIH RePORTER
P50 CA097190NCI NIH HHSUnited StatesP50CA097190PubMedNIH RePORTER
R01 AI166598NIAID NIH HHSUnited StatesR01AI166598PubMedNIH RePORTER
S10 OD032265NIH HHSUnited StatesS10OD032265PubMedNIH RePORTER
S10 OD032141NIH HHSUnited StatesS10OD032141PubMedNIH RePORTER
S10 OD023402NIH HHSUnited StatesS10OD023402PubMedNIH RePORTER

Download CSV of grants

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129255057Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29255057PubMed
233631227Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis.J Hepatol2021https://conductscience.org/library/papers/33631227PubMed
332603654Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.Cell2020https://conductscience.org/library/papers/32603654PubMed
434986285Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.N Engl J Med2022https://conductscience.org/library/papers/34986285PubMed
539675428Frequency and Consequences of Immune Checkpoint Inhibitor-Associated Inflammatory Changes in Different Organs: An Autopsy Study Over 13 -Years.Mod Pathol2025https://conductscience.org/library/papers/39675428PubMed
635115705Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.Nat Med2022https://conductscience.org/library/papers/35115705PubMed
727718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
834895481HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study.Lancet Oncol2022https://conductscience.org/library/papers/34895481PubMed
927745970L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity.Cell2016https://conductscience.org/library/papers/27745970PubMed
1036600271Patterns of toxicity burden for FDA-approved immune checkpoint inhibitors in the United States.J Exp Clin Cancer Res2023https://conductscience.org/library/papers/36600271PubMed
1134239137Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.Nat Med2021https://conductscience.org/library/papers/34239137PubMed
1221084662
Myelin-reactive, TGF-β-induced regulatory T cells can be programmed to develop Th1-like effector function but remain less proinflammatory than myelin-reactive Th1 effectors and can suppress pathogenic T cell clonal expansion in vivo.
J Immunol2010https://conductscience.org/library/papers/21084662PubMed
1338108398Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota Transplantation.Cancer Immunol Res2024https://conductscience.org/library/papers/38108398PubMed
1426282644
Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center.
J Clin Oncol2015https://conductscience.org/library/papers/26282644PubMed
1536720857Host-microbe co-metabolism via MCAD generates circulating metabolites including hippuric acid.Nat Commun2023https://conductscience.org/library/papers/36720857PubMed
1636309208Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.Gastroenterology2023https://conductscience.org/library/papers/36309208PubMed
1726872697Interleukin-35 Limits Anti-Tumor Immunity.Immunity2016https://conductscience.org/library/papers/26872697PubMed
1833571254A novel mouse model for checkpoint inhibitor-induced adverse events.PLoS One2021https://conductscience.org/library/papers/33571254PubMed
1923913274Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.Nature2013https://conductscience.org/library/papers/23913274PubMed
2022254078Folate production by probiotic bacteria.Nutrients2011https://conductscience.org/library/papers/22254078PubMed

See all 94 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42913630

GET https://conductscience.org/api/papers/v1/42913630/references?page=2